Dr. Casey Means

I don't know of, and I'm sure people can correct in the comments, but of a single chronic condition for which the explosion of the pill to treat and manage that condition has lessened the rates of that condition.

The more SSRIs you prescribe, the more depression we have.

The more metformin we prescribe, the more type 2 diabetes rates are going up.

The more Ozempic is being prescribed, obesity is going up.

This is on Wall Street.

They're not...

This is on track to be a blockbuster drug, and they're not assuming the rates of obesity are going to go down.

That wouldn't actually make sense for the business model.

I mean, these are being talked about at the JPMorgan healthcare conferences.

Do you think they're thinking that this is going to plummet?

No.

I can't think of very many chronic conditions for which the explosion of the medication has reduced the frequency of the disease.

That's really something to think about.

And the reason is because of exactly what we started this conversation with.

They're not actually truly impacting or healing the root cause physiology.

In some cases, they're worsening that root cause physiology, like they are inducing oxidative stress.

They may help with the symptomatic management.

But not actually reducing that trifecta that we talked about in the beginning.

And so why do we have reason to believe that medicalizing obesity and not actually getting at the root cause, which has to be impacted by obesity?

multimodal gentle nudges in our daily life habits and environment, that that's actually going to reduce the rates of the condition.